Orthofix Medical (OFIX) Gross Profit (2016 - 2025)
Orthofix Medical's Gross Profit history spans 16 years, with the latest figure at $156.3 million for Q4 2025.
- For the quarter ending Q4 2025, Gross Profit rose 5.04% year-over-year to $156.3 million, compared with a TTM value of $566.0 million through Dec 2025, up 3.69%, and an annual FY2025 reading of $566.0 million, up 3.69% over the prior year.
- Gross Profit for Q4 2025 was $156.3 million at Orthofix Medical, up from $148.5 million in the prior quarter.
- The five-year high for Gross Profit was $156.3 million in Q4 2025, with the low at $78.1 million in Q1 2022.
- Average Gross Profit over 5 years is $114.2 million, with a median of $119.7 million recorded in 2023.
- Year-over-year, Gross Profit surged 88.03% in 2021 and then dropped 7.97% in 2022.
- Tracing OFIX's Gross Profit over 5 years: stood at $91.8 million in 2021, then decreased by 2.87% to $89.2 million in 2022, then soared by 53.21% to $136.6 million in 2023, then increased by 8.94% to $148.8 million in 2024, then increased by 5.04% to $156.3 million in 2025.
- Per Business Quant, the three most recent readings for OFIX's Gross Profit are $156.3 million (Q4 2025), $148.5 million (Q3 2025), and $139.5 million (Q2 2025).